Na+-H+ exchange inhibition protects against mechanical, ultrastructural, and biochemical impairment induced by low concentrations of lysophosphatidylcholine in isolated rat hearts

Circulation Research

Volumn 80, Issue 1, 1997, Pages 95-102

  Ehsanul Hoque, A N ^a   Haist, James V ^a   Karmazyn, Morris ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

cardiac injury; isolated rat heart; lysophosphatidylcholine; myocyte; Na+ H+ exchange

Indexed keywords

4 ISOPROPYL 3 METHYLSULFONYLBENZOYLGUANIDINE METHANESULFONIC ACID; 5 (N ISOBUTYL N METHYL)AMILORIDE; ADENOSINE TRIPHOSPHATE; AMILORIDE DERIVATIVE; AMMONIUM CHLORIDE; ANTIPORTER; CARIPORIDE; CREATINE PHOSPHATE; GLYCOGEN; LACTIC ACID; LYSOPHOSPHATIDYLCHOLINE; MESYLIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; RAT; REPERFUSION INJURY;

EID: 0343907855     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.res.80.1.95     Document Type: Article

References (41)

1. + exchanger: an update on structure, regulation and cardiac physiology. Biochem J. 1993;296:273-285.
2. Lazdunski M, Frelin C, Vigne P. The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol. 1985;17:1029-1042.
3. + exchange in cardiac physiology and pathophysiology: mediation of myocardial reperfusion injury by the pH paradox. Cardiovasc Res. 1993;27:915-924.
4. + Exchange. Austin, Tex: Landes Bioscience Publishers; 1996:chap 10.
5. Pierce GW, Czubryt MP. The contribution of ionic imbalance to ischemia/reperfusion-indueed injury. J Mol Cell Cardiol. 1995;27:53-63.
6. Kinnaird AAA, Choy PC, Man RYK. Lysophosphatidylcholine accumulation in the ischemic canine heart. Lipids. 198823:32-35.
7. Mock T, Man RYK. Mechanism of lysophosphatidylcholine accumulation in the ischemic canine heart. Lipids. 1990;25:357-362.
8. Sobel BE, Corr PB, Robison AK, Goldstein RA, Witkowski FX, Klein MS. Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium. J Clin Invest. 1978;62:546-553.
9. Snyder DW, Crafford JRWA, Glashow JL, Rankin D, Sobel BE, Corr PB. Lysophosphoglycerides in ischemic myocardium effluents and potentiation of their arrhythmogenic effects. Am J Physiol. 1981;241:H700-H707.
10. Sargent CA, Vesterqvist O, Ogletree ML, Grover GJ. Effects of endogenous and exogenous lysophosphatidylcholine in isolated perfused rat hearts. J Mol Cell Cardiol. 1993;25:905-913.
11. Hoque ANE, Hoque N, Hashizume H, Abiko Y. A study of dilazep, II: dilazep attenuates lysophosphatidylcholine-induced mechanical and metabolic derangements in the isolated, working rat heart. Jpn J Pharmacol. 1995;67:233-241.
12. Oishi K, Raynor LR, Charp PA, Kuo JF. Regulation of protein kinase C by lysophospholipids: potential role in signal transduction. J Biol Chem. 1988;263:6865-6871.
13. Sasaki Y, Asaoka Y, Nishizuka Y. Potentiation of diacylglycerol-induced activation of protein kinase C by lysophospholipids. Fed Eur Biochem Soc. 1993;320:47-51.
14. + exchange. J Mol Celil Cardiol. 1988;20:493-500.
15. Scholz W, Albus U, Counillon L, Gögelein H, Lang H-J. Linz W, Weichert A, Schölkens BA. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res. 1995;29:260-268.
16. + exchange in mediating effects of endothelin-1 on normal and ischemic/reperfused hearts. Circ Res. 1994;75:369-378.
17. Moffat MP, Karmazyn M. Protective effects of the potent Na/H exchange inhibitor methylisobutyl amiloride against post-isehemic contractile dysfunction in rat and guinea-pig hearts. J Mol Cell Cardiol. 1993;25:959-971.
18. Bergmeyer HU. Methods in Enzymatic Analysts. New York, NY: Academic Press Inc; 1963.
19. Ebihara Y, Haist JV, Karmazyn M. Modulation of endothelin-1 effects on rat hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP. J Mol Cell Cardiol. 1996;28:265-277.
20. i. J Mol Cell Cardiol 1992;24:937-948.
21. Lagadic-Gossman D, Buckler KJ, Vaughan-Jones RD. Role of bicarbonate in pH recovery from intrazellular acidosis in the guinea-pig ventricular myocyte. J Physiol (Lond). 1992;458:361-364.
22. + exchanger: evidence for a receptor-mediated mechanism involving protein kinase C. Circ Res. 1996;79:705-715.
23. Fröhlich O, Wallert MA. Methods of measuring intracellular pH in the heart. Cardiovasc Res. 1995;29:194-202.
24. + exchange. Am J Physiol. 1988;255:H608-H615.
25. 2+ exchange. Circ Res. 1989;65:1045-1056.
26. Meng H-P, Pierce GN. Protective effects of 5-(N,N-dimethyl)-amiloride on ischemia-reperfusion injury in hearts. Am J Physiol. 1990;258:H1615-H1619.
27. Meng H-P, Maddaford TG, Pierce GN. Effect of amiloride and selected analogues on postischemic recovery of cardiac contractile function. Am J Physiol. 1993;264:H1831-H1835.
28. + exchange inhibitor and its effects on cardiac ischaemia. Br J Pharmacol. 1993;109:562-568.
29. 2+ homeostasis in the pH paradox of reperfusion injury to neonatal rat cardiac myocytes. Am J Physiol. 1993;265:C129-C137.
30. Sedlis SP, Sequeira JM, Altszuler HM. Coronary sinus lysophosphatidylcholine accumulation during rapid atrial pacing. Am J Cardiol. 1990;66:695-698.
31. Duan J, Moffat MP. Protective effects of D,L-carnitine against arrhythmias induced by lysophosphatidylcholine or reperfusion. Eur J Pharmacol. 1991;192:355-363.
32. Burnashev NA, Undrovinas AI, Fleidervish IA, Rosenshtraukh LV. Ischemic poison lysophosphatidylcholine modifies heart sodium channels gating inducing long-lasting bursts of openings. Pflugers Arch. 1989;415:124-126.
33. Burnashev NA, Undrovinas AI, Fleidervish IA, Makielski JC, Rosenshtraukh LV. Modulation of cardiac sodium channel gating by lysophosphatidylcholine. J Mol Cell Cardiol. 1991;23(suppl 1):23-30.
34. Undrovinas AI, Fleidervish IA, Makielski JC. Inward sodium current at resting potentials in single cardiac myocytes induced by the ischemic metabolite lysophosphatidylcholine. Circ Rev. 1992;71:1231-1241.
35. + concentration: a molecular basis for the antagonistic effect of ouabain and amiloride on the heart. J Biol Client. 1984;259:8880-8885.
36. +-ATPase. Am J Physiol. 1984;247:H840-H846.
37. Ohara Y, Peterson TE, Zheng B, Kuo JF, Harrison DG. Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation. Arterioscler Thromb. 1994;14:1007-1013.
38. Woodley SL, Ikenouchi H, Barry WH. Lysophosphatidylcholine increases cytosolic calcium in ventricular myocytes by direct action on the sarcolemma. J Mol Cell Cardiol. 1991;23:671-680.
39. Liu E, Goldhaber JI, Weiss JN. Effects of lysophosphatidylcholine on electrophysiological properties and excitation-contraction coupling in isolated guinea pig ventricular myocytes. J Clin Invest. 1991;88:1819-1832.
40. 2+-overload in isolated cardiomyocytes and effect of cytoprotective drugs. J Mol Cell Cardiol. 1992;24:977-988.
41. Ver Donck L, Borgers M. Myocardial protection by R 56865: a new principle based on prevention of ion channel pathology. Am J Physiol. 1991;261:H1828-H1835.